AptarGroup nasal spray tech joins ENA respiratory’s Phase II trial of INNA?051
$7 million grant to UW Institute for protein design to fuel next-gen enzyme breakthroughs
TRIANA Biomedicines doses first patient in groundbreaking ALK+ lung cancer trial
LGM Pharma commits $15M to US facilities in major CDMO expansion
Avid Organics launches first commercial-scale bio-based glycolic acid at in-cosmetics Global
Altesa BioSciences unveils breakthrough data on Rhinovirus Drug at ICAR2026
Government constitutes National Dental Commission to transform dental education
Glenmark slashes cost barrier with India launch of GLIPIQ diabetes therapy
Zydus launches affordable Semaglutide in India after patent expiry
Shionogi launches global Phase 2 trial for late-onset Pompe disease treatment
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1774270683)
